Register for real-time alerts, custom portfolio, and market movers

Get Started

OTIC

Otonomy (OTIC)

Otonomy Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OTIC

<< Previous 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next >>

Date	Time	Source	Headline	Symbol	Company
09/29/2016	7:30AM	GlobeNewswire Inc.	Otonomy to Host Investor and Analyst Day on October 7, 2016	NASDAQ:OTIC	Otonomy Inc
09/15/2016	7:30AM	GlobeNewswire Inc.	Otonomy Successfully Completes Open-Label Clinical Trial for OTIPRIO® in Patients with History of Otitis Media Requiring Ty...	NASDAQ:OTIC	Otonomy Inc
09/13/2016	7:30AM	GlobeNewswire Inc.	Otonomy Announces OTIPRIO® Data Presentation and Symposium at American Academy of Otolaryngology - Head and Neck Surgery Fou...	NASDAQ:OTIC	Otonomy Inc
09/08/2016	6:56PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OTIC	Otonomy Inc
09/01/2016	7:30AM	GlobeNewswire Inc.	Otonomy to Present at Baird Global Healthcare Conference	NASDAQ:OTIC	Otonomy Inc
08/04/2016	5:42PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OTIC	Otonomy Inc
08/04/2016	5:41PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:OTIC	Otonomy Inc
08/04/2016	4:09PM	GlobeNewswire Inc.	Otonomy Reports Second Quarter 2016 Financial Results and Provides Corporate Update	NASDAQ:OTIC	Otonomy Inc
08/04/2016	4:07PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:OTIC	Otonomy Inc
08/04/2016	4:03PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OTIC	Otonomy Inc
08/01/2016	7:30AM	GlobeNewswire Inc.	Otonomy Successfully Completes One-Year, Multiple-Dose Clinical Safety Trial for OTO-104 in Ménière’s Disease Patients	NASDAQ:OTIC	Otonomy Inc
07/28/2016	4:30PM	GlobeNewswire Inc.	Otonomy to Report Second Quarter 2016 Financial Results and Provide Corporate Update	NASDAQ:OTIC	Otonomy Inc
06/22/2016	4:32PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OTIC	Otonomy Inc
06/21/2016	7:50PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OTIC	Otonomy Inc
06/21/2016	7:48PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OTIC	Otonomy Inc
06/21/2016	7:47PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OTIC	Otonomy Inc
06/21/2016	7:45PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OTIC	Otonomy Inc
06/21/2016	7:43PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OTIC	Otonomy Inc
06/21/2016	7:32PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OTIC	Otonomy Inc
06/09/2016	7:30AM	GlobeNewswire Inc.	Otonomy Initiates Patient Enrollment in Single Phase 3 Clinical Trial of OTIPRIO™ in Patients with Acute Otitis Externa	NASDAQ:OTIC	Otonomy Inc
05/20/2016	7:30AM	GlobeNewswire Inc.	Otonomy Announces Assignment of C Code and Pass-Through Payment Status for OTIPRIO™	NASDAQ:OTIC	Otonomy Inc
05/16/2016	7:30AM	GlobeNewswire Inc.	Otonomy Announces OTIPRIO™ Data Presentation and Symposium at Combined Otolaryngology Spring Meetings	NASDAQ:OTIC	Otonomy Inc
05/09/2016	4:45PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:OTIC	Otonomy Inc
05/09/2016	4:42PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OTIC	Otonomy Inc
05/09/2016	4:16PM	GlobeNewswire Inc.	Otonomy Reports First Quarter 2016 Financial Results and Provides Corporate Update	NASDAQ:OTIC	Otonomy Inc
05/05/2016	7:30AM	GlobeNewswire Inc.	Otonomy to Present at the Bank of America Merrill Lynch Healthcare Conference	NASDAQ:OTIC	Otonomy Inc
04/28/2016	4:54PM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:OTIC	Otonomy Inc
04/18/2016	7:30AM	GlobeNewswire Inc.	Otonomy Announces Phase 3 Clinical Trial Plan for OTIPRIO™ in Otitis Externa Patients Based on Successful End-of-Phase 2 Re...	NASDAQ:OTIC	Otonomy Inc
03/23/2016	7:30AM	GlobeNewswire Inc.	Otonomy Initiates Patient Enrollment in Second Phase 3 Clinical Trial of OTO-104 in Ménière’s Disease	NASDAQ:OTIC	Otonomy Inc
03/18/2016	7:30AM	GlobeNewswire Inc.	Otonomy Announces Publication of OTIPRIO™ Phase 3 Clinical Trial Results in JAMA Otolaryngology	NASDAQ:OTIC	Otonomy Inc

Showing the most relevant articles for your search:NASDAQ:OTIC

<< Previous 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next >>

Astra Energy (QB)

Voip Pal Com (QB)

Ronn Motor (PK)

NioCorp Developments

Himalaya Technologies (PK)

Net Savings Link (PK)

Kraig Biocraft Laborator... (QB)

Lightwave Logic

Intergrated Cannabis Sol... (PK)

Rennova Health (PK)

Ethema Health (PK)

Northwest Biotherapeutics (QB)

RespireRx Pharmaceuticals (PK)

Anavex Life Sciences

Fannie Mae (QB)

Delayed Upgrade Clock